Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Health CatalystHCAT -3.46%49 Equity-to-Asset is 0.34 as of Mar. 2026, which is 35% below its 10-year median of 0.52. GuruFocus rates HCAT with a GF Score™ of 49/100 and a GF Value™ of $4.94 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 683 Healthcare Providers & Services companies, Health Catalyst ranks worse than 67.35% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Health Catalyst's Total Stockholders Equity for the quarter that ended in Mar. 2026 was $138.1 Mil. Health Catalyst's Total Assets for the quarter that ended in Mar. 2026 was $412.2 Mil.
Therefore, Health Catalyst's Equity to Asset Ratio for the quarter that ended in Mar. 2026 was 0.34.
The historical rank and industry rank for Health Catalyst's Equity-to-Asset or its related term are showing as below:
HCAT'
s Equity-to-Asset Range Over the Past 10 Years
Min: -3.99 Med: 0.52 Max: 0.66
Current: 0.34
During the past 9 years, the highest Equity to Asset Ratio of Health Catalyst was 0.66. The lowest was -3.99. And the median was 0.52.
HCAT's Equity-to-Asset is ranked worse than 67.35% of 683
companies
in the Healthcare Providers & Services industry
Industry Median: 0.48
vs HCAT: 0.34
Health Catalyst (NAS:HCAT) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Health Catalyst Equity-to-Asset Related Terms
Health Catalyst Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Health Catalyst's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
HCAT vs LFMD, AMWL, OPRX: Equity-to-Asset Comparison
For the Health Information Services subindustry, Health Catalyst's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Health Catalyst Equity-to-Asset vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Health Catalyst's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Health Catalyst's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Health Catalyst's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Health Catalyst (HCAT) has a Equity-to-Asset of 0.34 as of Mar. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Health Catalyst and its competitors. This is 35% below median its historical median of 0.52. According to the industry distribution chart, Health Catalyst ranks #460 out of 683 companies in the Healthcare Providers & Services industry, placing it in the top 67.3%.
Is Health Catalyst's Equity-to-Asset too high?
Health Catalyst's current Equity-to-Asset of 0.34 is 35% below median its 10-year median of 0.52. The Healthcare Providers & Services industry median Equity-to-Asset is 0.48. Health Catalyst's value of 0.34 is 29.2% below this industry median. Based on the distribution chart, Health Catalyst ranks #460 out of 683 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Health Catalyst has a GF Score™ of 49/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Health Catalyst's Equity-to-Asset compare to LFMD and AMWL?
According to the Healthcare Providers & Services industry distribution chart, Health Catalyst ranks #460 out of 683 companies for Equity-to-Asset. This places Health Catalyst in the lower half of its industry. The industry median Equity-to-Asset is 0.48. Health Catalyst's value of 0.34 is 29.2% below this benchmark. While the company's 10-year median is 0.52 vs. the industry median of 0.48, Health Catalyst has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Healthcare Providers & Services company?
The median Equity-to-Asset among Healthcare Providers & Services companies is 0.48, based on 683 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Health Catalyst's current Equity-to-Asset of 0.34 is 29.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Health Catalyst and its competitors. For the Healthcare Providers & Services industry, the median Equity-to-Asset is 0.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Health Catalyst's current Equity-to-Asset is 0.34, which is 35% below median its own 10-year median of 0.52. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Health Catalyst stock overvalued right now?
Based on GuruFocus' analysis, Health Catalyst (HCAT) is currently considered Possible Value Trap. The stock's GF Value™ is $4.94, compared to a current price of $2.10 — trading 57.6% below its estimated fair value. The current Equity-to-Asset is 0.34, which is 35% below median its 10-year median of 0.52 and 29.2% below the Healthcare Providers & Services industry median of 0.48. Health Catalyst's overall GF Score™ is 49/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Health Catalyst (HCAT), the current Equity-to-Asset is 0.34 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Health Catalyst (HCAT) Overvalued in 2026?
Based on GuruFocus' analysis, Health Catalyst stock appears to be undervalued.
The current stock price of $2.10 is trading 57.6% below its estimated GF Value™ of $4.94.
GuruFocus considers Health Catalyst to be Possible Value Trap.
Key valuation signals for HCAT:
Equity-to-Asset: 0.34 (35% below median its 10-year median of 0.52)
GF Value™: $4.94 vs. price of $2.10 (57.6% below fair value)
Industry Position: 29.2% below the Healthcare Providers & Services median (#460 of 683)
No single metric tells the full story. See the HCAT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Health Catalyst Inc provides data and analytics technology and services to healthcare organizations. It has two operating segments. The Technology segment, the key revenue driver, includes data platform, analytics applications and support services and generates revenues mainly from contracts that are cloud-based subscription arrangements, time-based license arrangements, and maintenance and support fees; the Professional Services segment is generally the combination of analytics, implementation, strategic advisory, outsourcing, and improvement services to deliver expertise to its customers to more fully configure and utilize the benefits of the technology offerings.
49GF Score
Get the complete analysis for HCAT
Equity-to-Asset is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HCAT has been successfully added to your 
